Trials / Completed
CompletedNCT00409305
The Effect of Betahistine on Body Weight in Obese Subjects
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 280 (planned)
- Sponsor
- OBEcure Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine the effect that betahistine has on body weight in obese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Betahistine | |
| BEHAVIORAL | Dietary counseling |
Timeline
- Start date
- 2007-01-01
- Completion
- 2007-06-01
- First posted
- 2006-12-08
- Last updated
- 2015-04-21
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00409305. Inclusion in this directory is not an endorsement.